Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Tepezza

PharmaCompass

01

Brand Name : Tepezza

Teprotumumab-trbw

arrow
FCE Pharma
Not Confirmed

Brand Name : Tepezza

arrow
FCE Pharma
Not Confirmed

Teprotumumab-trbw

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 448

2022 Revenue in Millions : 0

Growth (%) : Acquired from Horizon

blank

02

Brand Name : Tepezza

Teprotumumab

arrow
FCE Pharma
Not Confirmed

Brand Name : Tepezza

arrow
FCE Pharma
Not Confirmed

Teprotumumab

Main Therapeutic Indication : Immunology

Currency : USD

2024 Revenue in Millions : 1,851

2023 Revenue in Millions : 448

Growth (%) : 313

blank